MétaCan
Menu
Retour à la cohorte
Enregistrement W4280531656 · doi:10.1186/s12985-022-01813-2

NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study

2022· article· en· W4280531656 sur OpenAlexaff
Justin Reese, Ben Coleman, Lauren Chan, Hannah Blau, Tiffany J. Callahan, Luca Cappelletti, Tommaso Fontana, Katie R. Bradwell, Nomi L. Harris, Elena Casiraghi, Giorgio Valentini, Guy Karlebach, Rachel Deer, Julie A. McMurry, Melissa Haendel, Christopher G. Chute, Emily Pfaff, Richard A. Moffitt, Heidi Spratt, Jasvinder A. Singh, Chris Mungall, Andrew E. Williams, Peter N. Robinson

Notice bibliographique

RevueVirology Journal · 2022
Typearticle
Langueen
DomaineMedicine
ThématiqueCOVID-19 Clinical Research Studies
Établissements canadiensArtificial Intelligence in Medicine (Canada)
Organismes subventionnairesWake Forest Clinical and Translational Science Institute, Wake Forest School of MedicineBasic Energy SciencesNational Institute of General Medical SciencesNational Institute on AgingSouth Carolina Clinical and Translational Research Institute, Medical University of South CarolinaTranslational Research Institute, University of Arkansas for Medical SciencesCenter for Clinical and Translational Science, Mayo ClinicColorado Clinical and Translational Sciences InstituteCenter for Clinical and Translational Science, University of MassachusettsUniversity of Colorado DenverCenter for Clinical and Translational ResearchNational Center for Advancing Translational SciencesInstitute for Translational Sciences, University of Texas Medical BranchLeonard M. Miller School of MedicineOregon Clinical and Translational Research InstituteOffice of ScienceUniversity of Illinois at Urbana-ChampaignUniversity of Oklahoma Health Sciences CenterNational Institutes of HealthUniversity of Nebraska Medical CenterWest Virginia Clinical and Translational Science InstituteStony Brook UniversityLouisiana Clinical and Translational Science CenterTufts Medical CenterInstitute of Translational Health SciencesChildren's National HospitalUniversity of Arkansas for Medical SciencesVanderbilt University Medical CenterSouthern California Clinical and Translational Science InstituteUniversity of RochesterAurora Health CareUniversity of North Carolina at Chapel HillChildren’s Hospital of Wisconsin Research InstituteUniversity of MiamiUniversity of South CarolinaInstitute for Clinical and Translational Research, University of Wisconsin, MadisonPennsylvania State UniversityVanderbilt Institute for Clinical and Translational ResearchUniversity of CincinnatiInstitute of Clinical and Translational SciencesGeorgia Clinical and Translational Science AllianceIrving Medical Center, Columbia UniversityVirginia Commonwealth UniversityU.S. Department of EnergyUniversity of Wisconsin-MadisonTulane UniversityUniversity of Texas Medical BranchUniversity of Southern CaliforniaUniversity of OklahomaWashington University in St. LouisUniversity of MichiganUniversity of MinnesotaUniversity of PennsylvaniaGeorge Washington UniversityMichigan Institute for Clinical and Health ResearchUniversity of UtahJohns Hopkins UniversityBill and Melinda Gates FoundationUniversity of WashingtonOhio State UniversityWake Forest UniversityNorthwestern UniversityVanderbilt UniversityAccelerated Innovation Research Initiative Turning Top Science and Ideas into High-Impact ValuesUniversity of ChicagoChildren's Hospital ColoradoPenn State Clinical and Translational Science InstituteWest Virginia UniversityCarilion ClinicRush University
Mots-clésCoronavirus disease 2019 (COVID-19)Retrospective cohort studyCohortSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCenter (category theory)BiologyVirologyCohort studyMedicineInternal medicineOutbreakInfectious disease (medical specialty)Disease

Résumé

récupéré en direct d'OpenAlex

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to reduce pain, fever, and inflammation but have been associated with complications in community-acquired pneumonia. Observations shortly after the start of the COVID-19 pandemic in 2020 suggested that ibuprofen was associated with an increased risk of adverse events in COVID-19 patients, but subsequent observational studies failed to demonstrate increased risk and in one case showed reduced risk associated with NSAID use. METHODS: A 38-center retrospective cohort study was performed that leveraged the harmonized, high-granularity electronic health record data of the National COVID Cohort Collaborative. A propensity-matched cohort of 19,746 COVID-19 inpatients was constructed by matching cases (treated with NSAIDs at the time of admission) and 19,746 controls (not treated) from 857,061 patients with COVID-19 available for analysis. The primary outcome of interest was COVID-19 severity in hospitalized patients, which was classified as: moderate, severe, or mortality/hospice. Secondary outcomes were acute kidney injury (AKI), extracorporeal membrane oxygenation (ECMO), invasive ventilation, and all-cause mortality at any time following COVID-19 diagnosis. RESULTS: Logistic regression showed that NSAID use was not associated with increased COVID-19 severity (OR: 0.57 95% CI: 0.53-0.61). Analysis of secondary outcomes using logistic regression showed that NSAID use was not associated with increased risk of all-cause mortality (OR 0.51 95% CI: 0.47-0.56), invasive ventilation (OR: 0.59 95% CI: 0.55-0.64), AKI (OR: 0.67 95% CI: 0.63-0.72), or ECMO (OR: 0.51 95% CI: 0.36-0.7). In contrast, the odds ratios indicate reduced risk of these outcomes, but our quantitative bias analysis showed E-values of between 1.9 and 3.3 for these associations, indicating that comparatively weak or moderate confounder associations could explain away the observed associations. CONCLUSIONS: Study interpretation is limited by the observational design. Recording of NSAID use may have been incomplete. Our study demonstrates that NSAID use is not associated with increased COVID-19 severity, all-cause mortality, invasive ventilation, AKI, or ECMO in COVID-19 inpatients. A conservative interpretation in light of the quantitative bias analysis is that there is no evidence that NSAID use is associated with risk of increased severity or the other measured outcomes. Our results confirm and extend analogous findings in previous observational studies using a large cohort of patients drawn from 38 centers in a nationally representative multicenter database.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,005
score de la tête « metaresearch » (Gemma)0,073
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesMétarecherche, Intégrité de la recherche
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,068
Score d'incertitude au seuil1,000

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0050,073
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0010,000
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,001
Intégrité de la recherche0,0000,003
Charge utile insuffisante (le modèle a refusé de juger)0,0010,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,075
Tête enseignante GPT0,468
Écart entre enseignants0,394 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations31
Publié2022
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueVirology JournalMême sujetCOVID-19 Clinical Research StudiesTravaux en français237 207